“Working with limited supplies and imperfect scheduling systems, many pharmacists are drowning under a flood of inquiries. Wait lists, where they exist, are getting longer. And even creative solutions are succumbing to the cold realities of the day.”

Full Article

How is medical ethics debated in court? “If a Texas court ruling is allowed to stand, the state’s hospitals and doctors will have no room to make end-of-life care decisions based on independent medical ethics or individual conscience.”

Full Article

“Yet, design choices in the built health care environment raise substantive bioethical issues that demand the attention of bioethicists and ethical inquiry. It is time for the built environment to be considered alongside other parameters of care.”

Full Article

With efficacious medications available, ethics considers who has access to these drugs and who is at risk of losing them. Under COVID-19, the pandemic has accelerated the growth of many health disparities in the United States. Recently, there has been an increase in “pharmacy deserts”, where people struggle to fill medications locally because the drugs are no longer covered by Medicare of Medicaid.

Full Article

More and more microbes are becoming resistant to antimicrobial drugs, yet why are fewer antibiotics entering the market? For some, there is a lack of financial incentive to develop antibiotics and firms drop out in pursuit of more profitable drug lines.

Full Article

Can AI help doctors differentiate between COVID-19 and the regular flu? What information would the technology need and where should we draw those boundaries? Some models are showing promise by sifting through common health data.

Full Article

The drop, despite a strong economy, was the first since 2009 and at least partly caused by efforts to weaken the Affordable Care Act.

Full Article

Most hospitals do not frequently take patients to court over medical debt. But since 2015, Carlsbad Medical Center, in New Mexico, has filed lawsuits by the thousands.

Full Article

Full Article

A new Colorado law will ensure that those living with diabetes will spend no more than $100 per month on insulin, making it the first state to limit the cost of an increasingly expensive medication millions of Americans rely on.

Full Article